Universal Biosensors, Inc. (ASX:UBI)’s stock price traded up 5.4% on Thursday . The stock traded as high as A$0.20 ($0.14) and last traded at A$0.20 ($0.14), 641,313 shares were traded during trading. An increase of 859% from the average session volume of 66,890 shares. The stock had previously closed at A$0.19 ($0.13).
The company has a current ratio of 8.43, a quick ratio of 7.82 and a debt-to-equity ratio of 38.01. The stock has a market capitalization of $31.96 million and a PE ratio of 1.02. The firm’s fifty day moving average price is A$0.19 and its two-hundred day moving average price is A$0.21.
About Universal Biosensors (ASX:UBI)
Universal Biosensors, Inc, through its subsidiary, Universal Biosensors Pty Ltd, operates as a medical diagnostics company in Australia. It focuses on the research, development, and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The company uses electrochemical cell technology platform to develop point-of-care testing systems for various markets.
Receive News & Ratings for Universal Biosensors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Biosensors and related companies with MarketBeat.com's FREE daily email newsletter.